logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Prostate cancer: extended androgen suppression slows disease progression in long-term

High-dose-rate brachytherapy boost superior to dose-escalated EBRT for oncologic outcomes.